| 2023-01-30 | Regan Barry J. | EVP Operations | Sell | 2,213 | $106.12 | $234,843.56 | -3.6% | → |
| 2023-01-30 | SAYER KEVIN R | President CEO and Chairman of | Sell | 56,844 | $106.15 | $6,034,123.08 | -7.1% | → |
| 2023-01-23 | Pacelli Steven Robert | EVP Managing Director Dexcom V | Sell | 412 | $107.86 | $44,438.32 | -0.3% | → |
| 2023-01-20 | SAYER KEVIN R | President CEO and Chairman of | Sell | 45,607 | $105.75 | $4,822,871.84 | -9.7% | → |
| 2022-12-23 | Pacelli Steven Robert | EVP Managing Director Dexcom V | Sell | 412 | $112.57 | $46,378.84 | -0.3% | → |
| 2022-12-08 | Flynn Paul R | EVP Global Revenue | Sell | 8,988 | $123.50 | $1,110,018.00 | -13.9% | → |
| 2022-11-21 | Sylvain Jereme M | EVP Chief Financial Officer | Sell | 2,400 | $112.62 | $270,288.00 | -3.4% | → |
| 2022-09-01 | Dolan Matthew Vincent | SVP Corporate Strategy-Develop | Sell | 5 | $81.63 | $408.15 | - | → |
| 2022-08-23 | Pacelli Steven Robert | EVP Managing Director Dexcom V | Sell | 1,000 | $84.21 | $84,210.00 | -0.7% | → |
| 2022-07-25 | Pacelli Steven Robert | EVP Managing Director Dexcom V | Sell | 1,000 | $83.07 | $83,070.00 | -0.7% | → |
| 2022-06-23 | Pacelli Steven Robert | EVP Managing Director Dexcom V | Sell | 1,000 | $72.55 | $72,550.00 | -0.7% | → |
| 2022-06-06 | Sylvain Jereme M | EVP Chief Financial Officer | Sell | 600 | $301.57 | $180,942.00 | -3.3% | → |
| 2022-05-24 | Pacelli Steven Robert | EVP Managing Director Dexcom V | Sell | 250 | $296.33 | $74,082.50 | -0.7% | → |
| 2022-05-09 | Patterson Chad | EVP Global Marketing | Sell | 777 | $342.77 | $266,332.29 | -5.4% | → |
| 2022-04-25 | Pacelli Steven Robert | Managing Dir., Dexcom Ventures | Sell | 250 | $439.94 | $109,985.00 | -0.7% | → |
| 2022-04-11 | Patterson Chad | EVP, Global Marketing | Sell | 776 | $498.75 | $387,030.00 | -5.1% | → |
| 2022-03-29 | Regan Barry J. | EVP Global Operations | Sell | 1,106 | $500.00 | $553,000.00 | -6.3% | → |
| 2022-03-23 | Pacelli Steven Robert | Managing Dir., Dexcom Ventures | Sell | 250 | $459.98 | $114,995.00 | -0.7% | → |
| 2022-03-17 | Dolan Matthew Vincent | SVP Corporate Development | Sell | 2,186 | $424.68 | $928,358.56 | -9.2% | → |
| 2022-03-15 | SAYER KEVIN R | Chairman, CEO & President | Sell | 3,000 | $409.77 | $1,229,295.05 | -0.3% | → |
| 2022-03-10 | Patterson Chad | EVP, Global Marketing | Sell | 776 | $401.27 | $311,385.52 | -4.8% | → |
| 2022-03-10 | Selvaraj Shelly Ramasamy | SVP Chief Information Officer | Sell | 2,366 | $401.27 | $949,404.82 | -17.1% | → |
| 2022-03-04 | Sylvain Jereme M | EVP, Chief Financial Officer | Sell | 600 | $422.94 | $253,764.00 | -3.9% | → |
| 2022-03-01 | Patterson Chad | EVP, Global Marketing | Sell | 46 | $413.97 | $19,042.62 | -0.4% | → |
| 2022-02-23 | Pacelli Steven Robert | Managing Dir., Dexcom Ventures | Sell | 250 | $394.33 | $98,582.50 | -0.7% | → |
| 2022-02-14 | SAYER KEVIN R | Chairman, CEO & President | Sell | 3,000 | $418.04 | $1,254,120.00 | -3.1% | → |
| 2022-02-10 | KAHN BARBARA | Director | Sell | 3,966 | $441.23 | $1,749,904.02 | -5.6% | → |